Mastrandrea, Lucy D <br/><br/>
Liraglutide effects in a paediatric (7-11 y) population with obesity: A randomized, double-blind, placebo-controlled, short-term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics.  [electronic resource] 

 -  Pediatric obesity  05 2019 
 - e12495 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2047-6310 
<br/><br/><label>Standard No.: </label>10.1111/ijpo.12495  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Body Mass Index<br/>Body Weight--drug effects<br/>Child<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>Liraglutide--adverse effects<br/>Male<br/>Pediatric Obesity--drug therapy<br/>Treatment Outcome